| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 904,000 | 795,000 | 1,886,000 | 323,000 | | Cost of Revenue | 503,000 | 515,000 | 925,000 | 344,000 | | | Gross Profit | 401,000 | 280,000 | 961,000 | (21,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,000 | 31,000 | (189,000) | 276,000 | | Non Recurring | 438,000 | 48,000 | (57,000) | (26,000) | | Others | 92,000 | 94,000 | 91,000 | 93,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (167,000) | 107,000 | 1,116,000 | (364,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 38,000 | 11,000 | 24,000 | | Earnings Before Interest And Taxes | (155,000) | 39,000 | 1,123,000 | (350,000) | | Interest Expense | 98,000 | 105,000 | 105,000 | 108,000 | | Income Before Tax | (253,000) | (66,000) | 1,018,000 | (458,000) | | Income Tax Expense | 85,000 | (56,000) | 413,000 | (186,000) | | Minority Interest |
-
|
-
| 1,000 | 2,000 | | | | Net Income From Continuing Ops | (338,000) | (10,000) | 605,000 | (272,000) | | | Non-recurring Events | | Discontinued Operations | 1,000 | 3,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (337,000) | (7,000) | 605,000 | (272,000) | | Preferred Stock And Other Adjustments | 2,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($335,000) | ($7,000) | $605,000 | ($272,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
